You are here
Europe's vaccine campaign is accelerating. It expects to match the U.S. by July.
Primary tabs
Some European countries have helped their cause by sorting out logistical problems or enlisting family doctors and pharmacists to administer shots. But the bloc, more broadly, owes its turnaround to a deepened reliance on Pfizer-BioNTech, which has ramped up vaccine production — beyond what was initially expected — as other options have faltered or come too slowly.
Mostly using Pfizer, France’s pace of daily doses has increased 60 percent over the past month. Italy has accelerated by 90 percent. Germany by 145 percent.
While the United States has doses widely available to any adults who want them — and is struggling to find takers — many people in the E.U. are not yet eligible. But appointments are starting to open up in Europe, even for younger cohorts.
E.U. officials, noting President Biden’s target of getting at least one dose to 70 percent of U.S. adults by July 4, say that by midsummer Europeans and Americans will be in roughly the same situation.
“The U.S. has a similar goal, and this shows how much our vaccination campaigns are aligned by now,” said European Commission President Ursula von der Leyen.
The E.U. has so far administered at least one dose to 26 percent of its total population, compared to 45 percent in the United States, 52 percent in Britain and 60 percent in Israel. ...
Recent Comments